Johnson & Johnson scores 41/100 (Below expectations) on SINK's independent climate assessment — scored from public data only, no company payment can change a number. Last verified May 2026.
That places Johnson & Johnson joint 263rd of 691 companies scored, and 11th of 15 in Healthcare / Pharmaceuticals.
Johnson & Johnson reports comprehensive climate data with third-party verification but stalls on emissions reduction where it matters most: Scope 3 emissions are flat year-on-year despite revenue growth, and net-zero validation lapsed without revalidation. Nature and biodiversity impact remains largely unquantified. Systemic governance failures evident in 90,000+ talc litigation cases and deforestation-linked palm sourcing.
This score is built from public data only. If your practice is stronger than your disclosure, submit evidence for review — or challenge any question, free.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Carbon Footprint — Operations and Energy Source (7/10, 7/10). Weakest on Nature & Biodiversity Impact and Controversies & Red Flags (3/10, 4/10).
12 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
8 of 12 sources are third-party verified or public record.
If you believe a source has been misread or a newer version exists, submit a challenge.
Where Johnson & Johnson sits among healthcare / pharmaceuticals peers.
Among the 15 major healthcare / pharmaceuticals brands we've scored, Johnson & Johnson sits 11th of 15.
Score history begins 8 February 2026.
As Johnson & Johnson's score updates, the trajectory will appear here.
We're backfilling historical scores for FTSE 100 and S&P 100 companies over the coming weeks.
This score is not currently being contested.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
Johnson & Johnson is a diversified healthcare company headquartered in New Brunswick, New Jersey, operating across pharmaceuticals, medical devices, and consumer health. Founded in 1886, J&J is one of the world's largest healthcare conglomerates with 136,400 employees and FY2024 revenue of $88.8 billion. The company ranks in the top tier by scale but faces persistent product liability and supply chain governance challenges.
Peer pharmaceutical manufacturer facing similar supply-chain emissions stalls and regulatory compliance pressures.
View breakdown →Comparable healthcare multinational with higher renewable energy penetration and lower nature-related governance gaps.
View breakdown →Consumer-health peer with stronger biodiversity quantification but comparable litigation and supply-chain complexity.
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Been scored?
See what's behind your number →Nobody can pay us to change a number.